JP2024543187A5 - - Google Patents

Info

Publication number
JP2024543187A5
JP2024543187A5 JP2024531728A JP2024531728A JP2024543187A5 JP 2024543187 A5 JP2024543187 A5 JP 2024543187A5 JP 2024531728 A JP2024531728 A JP 2024531728A JP 2024531728 A JP2024531728 A JP 2024531728A JP 2024543187 A5 JP2024543187 A5 JP 2024543187A5
Authority
JP
Japan
Prior art keywords
pharmaceutical product
product according
sulfonic acid
formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024531728A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543187A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/083709 external-priority patent/WO2023094699A1/fr
Publication of JP2024543187A publication Critical patent/JP2024543187A/ja
Publication of JP2024543187A5 publication Critical patent/JP2024543187A5/ja
Pending legal-status Critical Current

Links

JP2024531728A 2021-11-29 2022-11-29 タウタンパク質の異常リン酸化及び凝集の阻害物質 Pending JP2024543187A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21306658.2 2021-11-29
EP21306658 2021-11-29
PCT/EP2022/083709 WO2023094699A1 (fr) 2021-11-29 2022-11-29 Inhibiteurs de la phosphorylation anormale et de l'agrégation de la protéine tau

Publications (2)

Publication Number Publication Date
JP2024543187A JP2024543187A (ja) 2024-11-19
JP2024543187A5 true JP2024543187A5 (cg-RX-API-DMAC10.html) 2025-11-28

Family

ID=78851140

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024531728A Pending JP2024543187A (ja) 2021-11-29 2022-11-29 タウタンパク質の異常リン酸化及び凝集の阻害物質

Country Status (6)

Country Link
US (1) US20250034194A1 (cg-RX-API-DMAC10.html)
EP (1) EP4441064A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024543187A (cg-RX-API-DMAC10.html)
CN (1) CN118922429A (cg-RX-API-DMAC10.html)
CA (1) CA3240163A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023094699A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240409505A1 (en) * 2023-06-12 2024-12-12 The Procter & Gamble Company Gluconamide sulfate surfactants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686603A (en) * 1995-05-04 1997-11-11 Lever Brothers Company, Division Of Conopco, Inc. Sulfated polyhydroxy compounds as anionic surfactants and a process for their manufacture
WO2007115372A1 (en) * 2006-04-10 2007-10-18 Monash University A method of modulating beta-amyloid peptide production

Similar Documents

Publication Publication Date Title
CN102906091B (zh) 苦参酸/碱衍生物及其制备方法和用途
CN111225896B (zh) 免疫调节剂化合物
JP6431155B2 (ja) フェノール誘導体及びその製造方法及び医薬的な応用
JP2017128605A (ja) 抗ウイルス化合物の固体形態
LV12515B (en) NON-FERTILIZING LIGANDS FOR ESTROGENE RECYCLES
CN116917280A (zh) 四氢萘类化合物、其制备方法及其在医药上的应用
JP2018528222A (ja) デングウイルス複製阻害剤としての一または二置換インドール誘導体
US9975856B2 (en) Process for the preparation of (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid
CN107848952B (zh) 稠合三环γ-氨基酸衍生物及其制备方法和在医药上的应用
KR20170005888A (ko) 신규 1-아릴-3-아자바이사이클로[3.1.0]헥산:제조 방법 및 신경 정신 질환 치료를 위한 용도
WO2004058744A1 (fr) Derive de 5-(4-bromophenyl)-1-(2,4-dichlorophenly)-4-ethyl-n-(piperidin-1-yl)-1h-pyrazole-3-carboxamide, sa preparation son application en therapeutique
EA029088B1 (ru) Макроциклические и бициклические ингибиторы вируса гепатита c
JP2025507851A5 (cg-RX-API-DMAC10.html)
ES2573004T3 (es) Compuestos bicíclicos de tetrahidropirrol
TW202000652A (zh) 飽和環稠合二氫嘧啶酮或二氫三酮化合物及其醫藥用途
CN103153297A (zh) 类萜类似物及其用于治疗神经病症的用途
IE67814B1 (en) Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases
TWI338687B (cg-RX-API-DMAC10.html)
WO2019108943A1 (en) Benzene fused heterocyclic compound and use thereof
AR069249A1 (es) Derivado de indazol, activo en el dolor neuropatico
KR20230172552A (ko) Tead 억제제
JP7734361B2 (ja) 化合物又はその塩及びその製造方法、化合物又はその塩を含む医薬品組成物及びその製造方法
CA2754384A1 (en) Pharmaceutical hypocholesterolemic compositions
ATE445589T1 (de) Neue retinoidderivate und eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält
KR101428496B1 (ko) 미토콘드리아 기능 조절에 활성을 지닌 트리아졸 유도체